The rat blood glutathione system under obesity development with the compatible consumption of the kidney bean (Phaseolus vulgaris) pods extract

A. Yurchenko, D. Krenytska, M. Tymoshenko
Taras Shevchenko National University of Kyiv, Kyiv; Taras Shevchenko National University of Kyiv, Kyiv; Taras Shevchenko National University of Kyiv, Kyiv


The state of the glutathione-dependent link of the antioxidant blood system of rats under obesity development and with the compatible consumption of the kidney bean (P. vulgaris) pods extract was studied.  Glutathione system forms functional basis of organism antioxidant defense system and disturbances in its work can lead to a number of serious cytotoxic and destructive lesions. Glutathione system constituent elements has its own glutathione and enzymes, which catalyze the reaction of its reverse transformation. These include glutathione peroxidase, glutathione transferase, and glutathione reductase. It is known that the water kidney bean (P. vulgaris) pods extract has hypoglycemic properties. However, complex studies of the polyfunctional action of this extract in obesity are absent. The obtained results indicate a decrease in the overall potential of the glutathione system in animals on a high-calorie diet. It has been established that glutathione peroxidase activity (GP) decreases in the serum of rats under experimental obesity, also glutathione transferase (GT) and glutathione reductase (GR) activity increase compared to the corresponding values in control animals. Our results demonstrated the concentration decrease of recovered glutathione (GSH) under consumption of high-calorie diet compared to the control. The findings after 6-th weeks of kidney bean (P. vulgaris) pods extract consumption indicate the positive modulating effect of this extract on the content of GSH and the activity of GP, GT and GR in rats with the obesity development. Probably, the consumption of this extract leads to attraction of the investigated components of the antioxidant system to the reactions of neutralization of toxic free radical compounds that were formed against the background of the development of obesity. Further studies may serve as the basis for the development of new therapeutic or medicinal preparations that based on the kidney bean (P. vulgaris) pods extract, because of still no consensus on the treatment of obesity.


obesity, kidney beans pods extract, high-calorie diet, glutathione system

Full Text:



References: 1. Бутрова С. А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению. Бутрова С. А. PМЖ. 2001; 2, №9: 5660. Українська.

Phelan S. Combining behavioral and pharmaco& logical treatments for obesity. Phelan S., Wadden T.A. Obes. Res. 2002; 10: 560–574. English.

Анциферов М.Б. Ожирение. Метаболический синдром. Сахарный диабет 2 типа. Анциферов М.Б. Под ред. акад. РАМН И.И. Дедо& ва. 2000; 53–61. Русский.

Khan V.N. Pharmacological appraisal of medicinal plants with antidiabetic potential. V.N. Khan, A.K. Najmi, M. Akhtar. J. Pharm. Bioallied. Sci. 2012; 4, №1: 27–42. English.

Ngoh Y.Y. Enzyme-assisted extraction and identification of antioxidative and α-amylase inhibitory peptides from Pinto beans (Phaseolus vulgaris cv. Pinto). Y.Y. Ngoh, C.Y. Gan. Food Chem. 2016; 190: 331-337. English.

Campbell P.M. Comparison of the α-amylase inhibitor-1 from common bean (Phaseolus vulgaris) varieties and transgenic expression in other legumes-post-translational modifications and immunogenicity. P.M. Campbell, D. Reiner, A.E. Moore [et al.]. Agric. Food. Chem. 2011; 59, № 11: 6047-6054. English.

Petlevski R. Effect of 'antidiabetis' herbal preparation on serum glucose and fructosamine in NOD mice. R. Petlevski, M. Hadzija, M. Slijepcevic, D. Juretic. Ethnopharmacol. 2001; 75, № 2-3: 181-184. English.

Kotaru M., Iwami K., Yeh H.Y., Ibuki F. In vivo action of alphaamylase inhibitor from cranberry bean (Phaseolus vulgaris) in rat small intestine. M. Kotaru, K. Iwami, H.Y. Yeh, F. Ibuki. J Nutr Sci Vitaminol (Tokyo). 1989; 35, № 6: 579-88. English.

Khaleeva L.D. Comparative evaluation of the hypoglycemic activity of the vegetal complex of Phaseolus vulgaris and chlorpropamide in experimental diabetes. L.D. Khaleeva, L.N. Maloshtan, A.G. Sytnik. Probl. Endokrinol. (Mosk). 1987; 33, № 2: 69-71. English.

Л. В. Вронська. Стандартизація сухого екстракту стулок квасолі за вмістом флавоноїдів. Л. В. Вронська. Медична та клінічна хімія. 2018; 20. № 1: 23-129. Українська.

Rondanelli M. Appetite Control and Glycaemia Reduction in Overweight Subjects treated with a Combination of Two Highly Standardized Extracts from Phaseolus vulgaris and Cynara scolymus. Rondanelli M., Giacosa A., Orsini F., Opizzi A., Villani S. Phytother. Res. 2011; 25(9): 1275-1282. English.

Spadafranca A. Phaseolus vulgaris extract affects glycometabolic and appetite control in healthy human subjects. Spadafranca A., Rinelli S., Riva A., Morazzoni P., Magni P., Bertoli S., Battezzati A. Br. J. Nutr. 2012. 1-7. English.

Barrett M.L. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control. Barrett M.L., Udani J.K. Nutr. J. 2011. 17, 10, 24. English.

Helmstädter A. Antidiabetic drugs used in Europe prior to the discovery of insulin. Helmstädter A. Pharmazie. 2007; 62(9): 717-720. English.

Hutchins A.M. Phaseolus beans: impact on glycaemic response and chronic disease risk in human subjects. Hutchins A.M., Winham D.M., Thompson S.V. Br. J. Nutr. 2012; 108 (1): 52-65. English.

Obiro W.C. The nutraceutical role of the Phaseolus vulgaris alphaamylase inhibitor. Obiro W.C., Zhang T., Jiang B. Br. J. Nutr. 2008; 100(1): 1-12. English.

Oomah B.D. Antioxidant and Antiinflammatory Activities of Bean (Phaseolus vulgaris L.) Hulls. Oomah B.D., Corbé A., Balasubramanian P. J. Agric. Food. Chem. 2010; 58(14): 8225-8230. English.

Балаболкин М.И. Свободно-радикальное окисление и антиоксидантная защита при сахарном диабете. Балаболкин М.И., Клебанова Е.М. Под ред. И.И. Дедова. 2003. 40. Русский.

Клебанов Г.И. Антиоксидантная активность сыворотки крови. Вестн. Клебанов Г.И., Теселкин Ю.О., Бабенкова И.В. и др. РАМН. 1999; 2: 15-21. Русский.

Бобырева Л.Е. Пробл. Эндокринологии. Бобырева Л.Е. 1996; 42 (6): 14 – 20. Русский.

Kalinina EV. Role of glutathione, glutathione transferase, and glutaredoxin in regulation of redox-dependent processes. Kalinina EV, Chernov NN, Novichkova MD. Biochemistry. 2014; 79(13): 1562-83. English.

Lissner L. Dietary fat and obesity: evidence from epidemiology. Lissner L., Heitmann B.L. European Journal of Clinical Nutrition. 1995; 49: 79-90. English.

Marcelo Genestra. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Marcelo Genestra Cellular Signalling. 2007; 19: 1807–1819. English.

Satish Balasaheb Nimse. Free radicals, natural antioxidants, and their reaction mechanisms. Satish Balasaheb Nimse., Dilipkumar Palb. RSC Advances. 2015; 35: 27986–28006. English.

Бєленічев І. Ф. Антиоксидантна система захисту організму (огляд). Бєленічев І. Ф., Левитський Д. Л., Коваленко С. І. Современные проблемы токсикологии. 2002; 3: 29– 31. Українська.

Василів O. Вплив сполук феруму мангану на вміст глутатіону у клітинах сірковідновлювальних бактерій Desulfuromonas acetoxidans. Василів O., Гнатуш С. Біологічні студії. 2011; 5(1): 5–10. Українська.

Акимишин M. M. Активність ензимів антиоксидантного захисту в рпродуктивних органах корів за норма та патології. Акимишин M. M., Кузьміна Н. В., Сачко Р. Г. Наук. вісник ЛНУВMБT ім. С.З. Гжицького. 2014; 2(59): 3–9. Українська.

Хайруллина В. Р. Экспериментальное и теоретическое исследование антирадикальной активности природных полифенолов. Хайруллина В. Р. Дис. ... канд. хим. наук: 02.00.04: Уфа. 2005; 180 c. Русский.

Chen C. K. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Chen C. K., Pace-Asciak C. R. General Pharmacol. 1996; N 2: 363–366. English.

Received in the editorial: 03.10.2018

Received a revised version: 04.10.2018

Signed in the press: 04.10.2018


  • There are currently no refbacks.

Лицензия Creative Commons
This journal is available according to the Creative Commons License «Attribution» («Атрибуція») 4.0 Global (CC-BY).